Cerebrospinal fluid sclerostin levels in the early Alzheimer's disease stages
Abstract INTRODUCTION Sclerostin, a negative regulator of bone formation, has been involved in memory impairment in Alzheimer's disease (AD) mouse models and is increased in elderly people at risk of AD. Here, we investigated sclerostin's role across the clinical stages of AD. METHODS We evaluated c...
Збережено в:
| Автори: | , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wiley
2026-01-01
|
| Серія: | Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1002/dad2.70297 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|